Exploring the Safety And Tolerability of Doses of E2007 up to a Maximum of 12 mg In Patients With Refractory Partial Seizures

NCT00416195 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

48

Enrollment

INDUSTRY

Sponsor class

Conditions

Epilepsy

Interventions

DRUG: E2007
DRUG: Placebo

Sponsor

Eisai Co., Ltd.

Collaborators

[object Object]